HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ali Amirkhosravi Selected Research

NA-LMWH

12/2006Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ali Amirkhosravi Research Topics

Disease

16Neoplasms (Cancer)
01/2016 - 02/2002
12Neoplasm Metastasis (Metastasis)
01/2016 - 06/2002
4Thrombosis (Thrombus)
01/2016 - 01/2010
4Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2015 - 08/2010
3Thrombocytopenia (Thrombopenia)
11/2015 - 09/2003
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2015 - 11/2004
3Hemorrhage
12/2006 - 06/2005
2Ovarian Neoplasms (Ovarian Cancer)
10/2016 - 01/2016
2Macular Degeneration (Age-Related Maculopathy)
01/2016 - 01/2016
2Necrosis
01/2015 - 11/2004
2Prostatic Neoplasms (Prostate Cancer)
06/2009 - 03/2007
2Experimental Melanoma
12/2006 - 06/2002
2Melanoma (Melanoma, Malignant)
12/2006 - 06/2002
1Vascular Diseases (Vascular Disease)
01/2016
1Venous Thromboembolism
01/2016
1Kidney Neoplasms (Kidney Cancer)
01/2016
1Rheumatoid Arthritis
11/2015
1Hypersensitivity (Allergy)
11/2015
1Anaphylaxis (Anaphylactic Shock)
11/2015
1Inflammation (Inflammations)
11/2015
1Autoimmune Diseases (Autoimmune Disease)
09/2015
1Proteinuria
09/2015
1Disseminated Intravascular Coagulation
01/2015
1Cardiovascular Diseases (Cardiovascular Disease)
03/2014
1Disease Progression
02/2014
1Thromboembolism
08/2010
1Acute-Phase Reaction
06/2009
1Thrombotic Microangiopathies
12/2007
1Thrombophilia
10/2007
1T-Cell Lymphoma (Lymphoma, T Cell)
11/2005
1Hematologic Neoplasms (Hematological Malignancy)
11/2004

Drug/Important Bio-Agent (IBA)

11Thromboplastin (Tissue Factor)IBA
10/2016 - 02/2002
5Proteins (Proteins, Gene)FDA Link
01/2016 - 02/2002
5AnticoagulantsIBA
01/2010 - 02/2002
4Thomsen-Friedenreich antigenIBA
01/2016 - 03/2007
4fibrin fragment D (D-dimer)IBA
01/2016 - 03/2007
3Bevacizumab (Avastin)FDA Link
01/2016 - 03/2012
3AntibodiesIBA
11/2015 - 04/2004
3Heparin (Liquaemin)FDA LinkGeneric
11/2015 - 02/2002
3CD40 Ligand (CD40L)IBA
09/2015 - 06/2005
3lipoprotein-associated coagulation inhibitor (TFPI)IBA
10/2007 - 02/2002
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2016 - 01/2016
2Immunoglobulin G (IgG)IBA
11/2015 - 09/2015
2Antigen-Antibody Complex (Immune Complex)IBA
11/2015 - 08/2010
2Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2010 - 02/2002
2AntigensIBA
03/2007 - 04/2004
2Peptides (Polypeptides)IBA
04/2004 - 09/2003
1Tumor Biomarkers (Tumor Markers)IBA
01/2016
1Ranibizumab (Lucentis)FDA Link
01/2016
1afliberceptIBA
01/2016
1Retinaldehyde (Retinal)IBA
01/2016
1pegaptanib (Macugen)FDA Link
01/2016
1Dihydrotachysterol (AT 10)IBA
11/2015
1IgG Receptors (Fc gamma RI)IBA
11/2015
1dapirolizumab pegolIBA
09/2015
1Biomarkers (Surrogate Marker)IBA
01/2015
1Lactate Dehydrogenase 5IBA
01/2015
1Dacarbazine (DIC)FDA LinkGeneric
01/2015
1A 7 (A-7)IBA
03/2014
1Immunoconjugates (Immunoconjugate)IBA
02/2014
1Factor VIIa (Activated Factor VII)IBA
02/2014
1Antineoplastic Agents (Antineoplastics)IBA
02/2014
1auristatinIBA
02/2014
1HirudinsIBA
03/2012
1CX3C Chemokine Receptor 1IBA
03/2012
1Fc gamma receptor IIAIBA
08/2010
1LigandsIBA
01/2009
1Aprotinin (Trasylol)FDA Link
12/2007
1Prostate-Specific Antigen (Semenogelase)IBA
03/2007
1NA-LMWHIBA
12/2006
1Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
12/2006
1Enoxaparin (Lovenox)FDA LinkGeneric
12/2006
1Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
11/2005
1Factor Xa (Coagulation Factor Xa)IBA
11/2005
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2004
1Therapeutic UsesIBA
11/2004
1Hemostatics (Antihemorrhagics)IBA
11/2004
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
11/2004
1CytosineIBA
11/2004
1Daunorubicin (Cerubidine)FDA LinkGeneric
11/2004
1EpitopesIBA
04/2004
1Tumor Suppressor Protein p53IBA
04/2004
1Membrane Proteins (Integral Membrane Proteins)IBA
04/2004
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
04/2004
1Coloring Agents (Dyes)IBA
04/2004
1XV 454IBA
09/2003
1Abciximab (ReoPro)FDA Link
02/2002
1Monoclonal AntibodiesIBA
02/2002
1Concanavalin AIBA
02/2002
1FibrinIBA
02/2002
1Warfarin (Coumadin)FDA LinkGeneric
02/2002

Therapy/Procedure

9Therapeutics
01/2016 - 02/2002
3Immunotherapy
08/2010 - 04/2004
1Prostatectomy (Retropubic Prostatectomy)
06/2009
1Intravenous Administration
09/2003
1Intravenous Injections
06/2002